Literature DB >> 25022876

Disclosure of selective advantages in the "modern" sublineage of the Mycobacterium tuberculosis Beijing genotype family by quantitative proteomics.

Jeroen de Keijzer1, Petra E de Haas2, Arnoud H de Ru3, Peter A van Veelen3, Dick van Soolingen4.   

Abstract

The Mycobacterium tuberculosis Beijing genotype, consisting of the more ancient (atypical) and modern (typical) emerging sublineage, is one of the most prevalent and genetically conserved genotype families and has often been associated with multidrug resistance. In this study, we employed a 2D-LC-FTICR MS approach, combined with dimethylation of tryptic peptides, to systematically compare protein abundance levels of ancient and modern Beijing strains and identify differences that could be associated with successful spread of the modern sublineage. The data is available via ProteomeXchange using the identifier PXD000931. Despite the highly uniform protein abundance ratios in both sublineages, we identified four proteins as differentially regulated between both sublineages, which could explain the apparent increased adaptation of the modern Beijing strains. These proteins are; Rv0450c/MmpL4, Rv1269c, Rv3137, and Rv3283/sseA. Transcriptional and functional analysis of these proteins in a large cohort of 29 Beijing strains showed that the mRNA levels of Rv0450c/MmpL4 are significantly higher in modern Beijing strains, whereas we also provide evidence that Rv3283/sseA is less abundant in the modern Beijing sublineage. Our findings provide a possible explanation for the increased virulence and success of the modern Beijing sublineage. In addition, in the established dataset of 1817 proteins, we demonstrate the pre-existence of several, possibly unique, antibiotic efflux pumps in the proteome of the Beijing strains. This may reflect an increased ability of Beijing strains to escape exposure to antituberculosis drugs.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25022876      PMCID: PMC4188992          DOI: 10.1074/mcp.M114.038380

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  87 in total

1.  Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes.

Authors:  A Krogh; B Larsson; G von Heijne; E L Sonnhammer
Journal:  J Mol Biol       Date:  2001-01-19       Impact factor: 5.469

2.  Mutations in the regulatory network underlie the recent clonal expansion of a dominant subclone of the Mycobacterium tuberculosis Beijing genotype.

Authors:  Anita C Schürch; Kristin Kremer; Robin M Warren; Nguyen V Hung; Yanlin Zhao; Kanglin Wan; Martin J Boeree; Roland J Siezen; Noel H Smith; Dick van Soolingen
Journal:  Infect Genet Evol       Date:  2011-01-28       Impact factor: 3.342

3.  Rifampicin reduces susceptibility to ofloxacin in rifampicin-resistant Mycobacterium tuberculosis through efflux.

Authors:  Gail E Louw; Robin M Warren; Nicolaas C Gey van Pittius; Rosalba Leon; Adelina Jimenez; Rogelio Hernandez-Pando; Christopher R E McEvoy; Melanie Grobbelaar; Megan Murray; Paul D van Helden; Thomas C Victor
Journal:  Am J Respir Crit Care Med       Date:  2011-04-21       Impact factor: 21.405

4.  DNA fingerprinting of Mycobacterium tuberculosis: from phage typing to whole-genome sequencing.

Authors:  Anita C Schürch; Dick van Soolingen
Journal:  Infect Genet Evol       Date:  2011-11-03       Impact factor: 3.342

5.  Rapid and simple method for purification of nucleic acids.

Authors:  R Boom; C J Sol; M M Salimans; C L Jansen; P M Wertheim-van Dillen; J van der Noordaa
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

6.  Genetic diversity of Mycobacterium tuberculosis isolates from Inner Mongolia, China.

Authors:  Qin Yu; Yunkai Su; Bing Lu; Yan Ma; Xiuqin Zhao; Xiaomin Yang; Haiyan Dong; Yao Liu; Lulu Lian; Li Wan; Yimou Wu; Kanglin Wan
Journal:  PLoS One       Date:  2013-05-01       Impact factor: 3.240

7.  Super-SILAC allows classification of diffuse large B-cell lymphoma subtypes by their protein expression profiles.

Authors:  Sally J Deeb; Rochelle C J D'Souza; Jürgen Cox; Marc Schmidt-Supprian; Matthias Mann
Journal:  Mol Cell Proteomics       Date:  2012-03-21       Impact factor: 5.911

8.  Using a label-free proteomics method to identify differentially abundant proteins in closely related hypo- and hypervirulent clinical Mycobacterium tuberculosis Beijing isolates.

Authors:  Gustavo A de Souza; Suereta Fortuin; Diana Aguilar; Rogelio Hernandez Pando; Christopher R E McEvoy; Paul D van Helden; Christian J Koehler; Bernd Thiede; Robin M Warren; Harald G Wiker
Journal:  Mol Cell Proteomics       Date:  2010-02-26       Impact factor: 5.911

9.  Beijing/W genotype Mycobacterium tuberculosis and drug resistance.

Authors: 
Journal:  Emerg Infect Dis       Date:  2006-05       Impact factor: 6.883

10.  Accurate prediction of the functional significance of single nucleotide polymorphisms and mutations in the ABCA1 gene.

Authors:  Liam R Brunham; Roshni R Singaraja; Terry D Pape; Anish Kejariwal; Paul D Thomas; Michael R Hayden
Journal:  PLoS Genet       Date:  2005-12-30       Impact factor: 5.917

View more
  14 in total

Review 1.  Systems proteomics approaches to study bacterial pathogens: application to Mycobacterium tuberculosis.

Authors:  Amir Banaei-Esfahani; Charlotte Nicod; Ruedi Aebersold; Ben C Collins
Journal:  Curr Opin Microbiol       Date:  2017-10-13       Impact factor: 7.934

Review 2.  Circulation of M. tuberculosis Beijing genotype in Latin America and the Caribbean.

Authors:  M I Cerezo-Cortés; J G Rodríguez-Castillo; R Hernández-Pando; M I Murcia
Journal:  Pathog Glob Health       Date:  2020-01-05       Impact factor: 2.894

3.  Host-pathogen genetic interactions underlie tuberculosis susceptibility in genetically diverse mice.

Authors:  Clare M Smith; Richard E Baker; Megan K Proulx; Bibhuti B Mishra; Jarukit E Long; Sae Woong Park; Ha-Na Lee; Michael C Kiritsy; Michelle M Bellerose; Andrew J Olive; Kenan C Murphy; Kadamba Papavinasasundaram; Frederick J Boehm; Charlotte J Reames; Rachel K Meade; Brea K Hampton; Colton L Linnertz; Ginger D Shaw; Pablo Hock; Timothy A Bell; Sabine Ehrt; Dirk Schnappinger; Fernando Pardo-Manuel de Villena; Martin T Ferris; Thomas R Ioerger; Christopher M Sassetti
Journal:  Elife       Date:  2022-02-03       Impact factor: 8.140

4.  Genetic features of Mycobacterium tuberculosis modern Beijing sublineage.

Authors:  Qingyun Liu; Tao Luo; Xinran Dong; Gang Sun; Zhu Liu; Mingyun Gan; Jie Wu; Xin Shen; Qian Gao
Journal:  Emerg Microbes Infect       Date:  2016-02-24       Impact factor: 7.163

5.  Proteome analysis of the Mycobacterium tuberculosis Beijing B0/W148 cluster.

Authors:  Julia Bespyatykh; Egor Shitikov; Ivan Butenko; Ilya Altukhov; Dmitry Alexeev; Igor Mokrousov; Marine Dogonadze; Viacheslav Zhuravlev; Peter Yablonsky; Elena Ilina; Vadim Govorun
Journal:  Sci Rep       Date:  2016-06-30       Impact factor: 4.379

6.  The best of respiratory infections from the 2015 European Respiratory Society International Congress.

Authors:  Eva Polverino; Graham H Bothamley; Delia Goletti; Jan Heyckendorf; Giovanni Sotgiu; Stefano Aliberti
Journal:  ERJ Open Res       Date:  2016-07-11

7.  A Comparison of the Sensititre MycoTB Plate, the Bactec MGIT 960, and a Microarray-Based Molecular Assay for the Detection of Drug Resistance in Clinical Mycobacterium tuberculosis Isolates in Moscow, Russia.

Authors:  Elena Y Nosova; Danila V Zimenkov; Anastasia A Khakhalina; Alexandra I Isakova; Ludmila Y Krylova; Marina V Makarova; Ksenia Y Galkina; Maria A Krasnova; Svetlana G Safonova; Vitaly I Litvinov; Dmitry A Gryadunov; Elena M Bogorodskaya
Journal:  PLoS One       Date:  2016-11-30       Impact factor: 3.240

8.  Proteomics for the Investigation of Mycobacteria.

Authors:  J A Bespyatykh; E A Shitikov; E N Ilina
Journal:  Acta Naturae       Date:  2017 Jan-Mar       Impact factor: 1.845

9.  A temporal proteome dynamics study reveals the molecular basis of induced phenotypic resistance in Mycobacterium smegmatis at sub-lethal rifampicin concentrations.

Authors:  Alexander D Giddey; Elise de Kock; Kehilwe C Nakedi; Shaun Garnett; Andrew J M Nel; Nelson C Soares; Jonathan M Blackburn
Journal:  Sci Rep       Date:  2017-03-06       Impact factor: 4.379

Review 10.  Potential Alternative Strategy against Drug Resistant Tuberculosis: A Proteomics Prospect.

Authors:  Divakar Sharma; Deepa Bisht; Asad U Khan
Journal:  Proteomes       Date:  2018-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.